Ofelia Baniandrés Rodríguez

6PUBLICATIONS
65CO-AUTHORS
MultimorbidityHaematological tumoursPredictive and prognostic markersImmunogenetics (incl. genetic immunology)Information systems development methodologies and practice
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Dec 05, 2025
Efficacy and Safety of Risankizumab in Psoriatic Patients With a History of Malignancy: Real-World Evidence From a Multicentre Spanish Study.

Javier Mataix Díaz, Sergio Santos Alarcón, Isabel Belinchón Romero

|Sep 11, 2025
Tildrakizumab in Psoriatic Patients With Current or Past Malignancy: A Real-Life Cohort and Literature Review.

Ofelia Baniandrés, Inmaculada Balaguer Franch, Eva Vilarrasa Rull

|Jun 16, 2025
New Model of Integrated Care for Patients with Immune-Mediated Inflammatory Diseases.

Esther Chamorro-de-Vega, C M González, L Menchén

|Sep 13, 2022
Information and Communication Technologies in Patients With Immune-Mediated Inflammatory Diseases: Cross-sectional Survey.

Esther Chamorro-de-Vega, Rosa Romero-Jiménez, Vicente Escudero-Vilaplana

|Apr 30, 2020
Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases.

C Galván Casas, A Català, G Carretero Hernández

Pageof 1